Global Longlife Hospital And Research Ltd Share Price & Stock Analysis

Global Longlife Hospital And Research Ltd (BSE: 543520) is an Ahmedabad, Gujarat-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹14 Cr, it ranks #4,618 by market cap among the 6,197 Indian listed companies on FinBizNet, and #42 of 46 in Hospitals and Healthcare Centers. At ₹13.43 (as of 16 Nov 2026), the share price is 47.5% below its 52-week high of ₹25.60 and 49.2% above its 52-week low of ₹9.00. The share price is down 44.7% over one year and up 11.1% over three months.

Key Metrics

Current Price₹13.43
Market Cap₹14 Cr
BSE Code543520
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Facilities > Hospitals and Healthcare Centers
P/E RatioNot meaningful (loss)
Return on Equity-6.80%
Return on Assets-2.45%
52-Week Range₹9.00 – ₹25.60
1-Year Price Change-44.7%
3-Month Price Change+11.1%
Beta (1Y)0.04
HeadquartersAhmedabad, Gujarat
Websiteglobalhospital.co.in

Shareholding and Delivery

Delivery averaged 87.5% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Global Longlife Hospital And Research Ltd

Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. The company offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary,

Products and Services

1. Healthcare Facilities & Services-This segment engages in the multispecialty hospital business.

Global Longlife Hospital And Research Ltd vs Peers — Hospitals and Healthcare Centers

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Apollo Hospitals Enterprise Limited₹1,23,712 Cr6321.50%₹7,615 Cr+11.6%
Max Healthcare Institute Ltd₹91,978 Cr63.914.33%₹2,569 Cr-16.6%
Manipal Health Enterprises Ltd₹89,110 Cr88.4—₹3,399 Cr—
Aster Dm Healthcare Limited (Asterdm)₹63,041 Cr97.610.07%₹2,829 Cr+4.3%
Fortis Healthcare Ltd.₹58,283 Cr55.111.01%₹2,735 Cr-25.1%
Global Health Ltd (Medanta)₹38,422 Cr69.715.03%₹1,469 Cr+16.2%
Narayana Hrudayalaya Limited₹37,907 Cr46.219.85%₹2,844 Cr+2.8%
Krishna Institute Of Medical Science (KIMS)₹29,056 Cr120.69.72%₹1,344 Cr+0.2%
Global Longlife Hospital And Research Ltd₹14 Crn/m-6.80%—-44.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Global Longlife Hospital And Research Ltd?

Global Longlife Hospital And Research Ltd is trading at ₹13.43, with a market capitalisation of ₹14 Cr.

Which sector does Global Longlife Hospital And Research Ltd belong to?

Global Longlife Hospital And Research Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).

What are the key financial ratios of Global Longlife Hospital And Research Ltd?

Global Longlife Hospital And Research Ltd has a return on equity of -6.80%.

What is the stock symbol of Global Longlife Hospital And Research Ltd?

Global Longlife Hospital And Research Ltd is listed on the BSE under the scrip code 543520.

How has Global Longlife Hospital And Research Ltd's share price moved over the past year?

Global Longlife Hospital And Research Ltd's share price is down 44.7% over one year and up 11.1% over three months. Its 52-week range is ₹9.00 to ₹25.60.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.